Windsor Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$262K Buy
+3,616
New +$243K 0.12% 58
2016
Q1
Sell
-3,890
Closed -$230K 75
2015
Q4
$230K Hold
3,890
0.11% 70
2015
Q3
$212K Sell
3,890
-355
-8% -$23.1K 0.1% 73
2015
Q2
$285K Hold
4,245
0.12% 74
2015
Q1
$249K Sell
4,245
-1,000
-19% -$60.4K 0.11% 78
2014
Q4
$343K Buy
+5,245
New +$331K 0.16% 67

Other funds holding ABBV

Windsor Financial Group's ABBV Position: Q2 2017 in Review

Windsor Financial Group opened a new position in AbbVie (ABBV) in Q2 2017: 3,616 shares worth $262K. The stake represents 0.12% of the portfolio and ranks #58 among its holdings. This is a return to the name: Windsor Financial Group previously reported a position in ABBV as recently as Q4 2015.

Windsor Financial Group first reported a position in ABBV in Q4 2014 and has held it in 6 quarters since. The position peaked at $343K in Q4 2014. 1,763 funds tracked by Wall St. Rank hold ABBV as of Q2 2017.

  • Windsor Financial Group held 3,616 shares of AbbVie worth $262K as of Q2 2017.
  • AbbVie was a new Windsor Financial Group position in Q2 2017.
  • AbbVie made up 0.12% of Windsor Financial Group's portfolio in Q2 2017, its #58 holding.
  • Windsor Financial Group first reported a position in AbbVie in Q4 2014 and has held it in 6 quarters since.
  • Windsor Financial Group's AbbVie position peaked at $343K in Q4 2014.
  • 1,763 funds tracked by Wall St. Rank held AbbVie as of Q2 2017.

Based on Windsor Financial Group's 13F filing for Q2 2017, filed 3 Aug 2017.